84. サルコイドーシス [臨床試験数:143,薬物数:221(DrugBank:79),標的遺伝子数:82,標的パスウェイ数:165

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04314193
(ClinicalTrials.gov)
June 1, 202024/2/2020Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary SarcoidosisThe PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled TrialSarcoidosis, PulmonaryDrug: Methotrexate;Drug: PrednisoloneErasmus Medical CenterSt. Antonius Hospital;LongfondsRecruiting18 YearsN/AAll138Phase 4Netherlands
2NCT03705884
(ClinicalTrials.gov)
January 1, 20188/8/2018PET/MR Imaging In Patients With Cardiac SarcoidosisMolecular Imaging in Cardiovascular Disease Using Hybrid Positron Emission Tomography/Magnetic Resonance Imaging (PET/MR): Cardiac SarcoidosisCardiac SarcoidosisOther: 18F-FDG;Drug: PrednisoloneUniversity of EdinburghNULLUnknown status40 YearsN/AAll40N/AUnited Kingdom
3NCT03324503
(ClinicalTrials.gov)
December 8, 201712/10/2017A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary SarcoidosisA Multicenter, Open-Label Study to Estimate the Effect Sizes of HRCT Endpoints in Response to GLUCOCORTICOID Induction Therapy in Subjects With Pulmonary SarcoidosisSarcoidosis, PulmonaryDrug: Glucocorticoid (prednisone or prednisolone)CelgeneNULLCompleted18 Years65 YearsAll8N/AUnited States;Netherlands;United Kingdom
4JPRN-UMIN000025936
2017/06/1220/02/2017Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial Cardiac sarcoidosiscombination therapy group:
Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg.
Antimicrobial agent; Clarithromycin start from 400mg/day for 24weeks. Doxycycline start 100mg/day for 22 weeks after 2 months of clarithromycin therapy.

Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg.
National cerebral and cardiovascular centerNULLRecruiting20years-oldNot applicableMale and Female80Not selectedJapan
5NCT03265405
(ClinicalTrials.gov)
April 1, 201723/8/2017Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of SarcoidosisEfficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis: a Randomized Controlled TrialSarcoidosisDrug: Low dose prednisolone;Drug: Medium dose prednisolonePostgraduate Institute of Medical Education and ResearchNULLRecruiting18 Years65 YearsAll86Phase 4India
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT01245036
(ClinicalTrials.gov)
January 200915/11/2010Efficacy of Antituberculous Therapy in Management of SarcoidosisRifampicin and Isoniazid Along With Prednisolone Compared to Prednisolone Alone in Treatment of Sarcoidosis: a Pilot Randomized Controlled TrialSarcoidosis;TuberculosisDrug: Antituberculous therapy along with steroidsPostgraduate Institute of Medical Education and ResearchNULLCompleted15 Years75 YearsBoth100N/AIndia